# A2i Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/a2i-therapeutics

- Industry: Biotechnology
- Headquarters: Israel
- Website: www.a2i-tx.com
- Latest round: Seed (Dec 18, 2020)
- Investors on record: 4

## About

A2i Therapeutics was formed as a joint venture between Atomwise and FutuRx. The company operates as a developer of novel small molecule immuno-oncology agents.

## Funding rounds

- Seed, Dec 18, 2020 — OrbiMed Advisors, Johnson & Johnson Innovation, Takeda Ventures, FutuRX

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Seed
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Seed
- Takeda Ventures (https://capitalatlas.ai/funds/takeda-ventures) — Seed
- FutuRX (https://capitalatlas.ai/funds/futurx) — Seed